3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neoplasm Metastasis
2
Lung Neoplasms
2
Brain Neoplasms
2
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Thyroid Cancer, Papillary
1
Prostatic Neoplasms
1
Precancerous Conditions
1
Pleural Effusion, Malignant
1
Osteoporosis
1
Neoplasms
1
Lymphatic Metastasis
1
Gliosarcoma
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma Of Esophagus
1
Interventions
Indocyanine Green
7
Radiotherapy
4
Magnetic Resonance Spectroscopy
4
Lymph Node Excision
4
Cisplatin
4
Surgical Procedures, Operative
3
Specimen Handling
3
Radiotherapy, Intensity-Modulated
3
Radiosurgery
3
gadofosveset trisodium
2
Technetium
2
TP protocol
2
Sentinel Lymph Node Biopsy
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Ipilimumab
2
Electroporation
2
Conversion to Open Surgery
2
Control Groups
2
tislelizumab
1
radium Ra 223 dichloride
1
peposertib
1
pembrolizumab
1
gewf solution
1
encorafenib
1
cabozantinib
1
binimetinib
1
avelumab
1
alovudine
1
X-Rays
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Lymphatic Metastasis
×
Spectrum Analysis
×
Clear all
NCT03470259
2024-04-16
TARGET
University Medical Center Groningen
Phase 1
Completed
19 enrolled